A study of healthy volunteers ( N = 41) investigated whether oral semaglutide could potentially influence exposure to furosemide or rosuvastatin
One Boston startup working on patches, Anodyne Nanotech, is focusing initially on the GLP-1 weight loss drugs
NICE guidance recommends regular review of patients taking GLP-1 agonists, typically every 3-6 months, to assess treatment response, side effects, and ongoing appropriateness of therapy
You have successfully joined our Friday 5 Newsletter subscriber list
If youre starting semaglutide treatment and want guidance on which formulation is right for your situation, the intake assessment at TrimRx connects you with a provider who can match treatment details, including formulation considerations, to your individual health profile